These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11783506)

  • 21. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
    Cheson BD
    Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone.
    Chow KU; Rummel MJ; Weidmann E; Ries J; Jantschke P; Boehrer S; Pourebrahim F; Napieralski S; Stein J; Martin H; Hoelzer D; Mitrou PS
    Leuk Lymphoma; 2000 Feb; 36(5-6):559-67. PubMed ID: 10784401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Chlorodeoxyadenosine in the treatment of multiple myeloma.
    Dimopoulos MA; Kantarjian HM; Estey EH; Alexanian R
    Blood; 1992 Sep; 80(6):1626. PubMed ID: 1355673
    [No Abstract]   [Full Text] [Related]  

  • 24. Bilateral facial nerve palsy as first indication of relapsing hairy cell leukemia after 36 years.
    Ferrari J; Lang W; Thurnher S; Müllauer L; Raderer M
    Neurology; 2004 Jul; 63(2):399-400. PubMed ID: 15277655
    [No Abstract]   [Full Text] [Related]  

  • 25. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
    Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
    Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
    Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine.
    Trendle MC; Tefferi A
    N Engl J Med; 1994 Apr; 330(15):1090. PubMed ID: 8127350
    [No Abstract]   [Full Text] [Related]  

  • 28. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
    Santana VM; Mirro J; Kearns C; Schell MJ; Crom W; Blakley RL
    J Clin Oncol; 1992 Mar; 10(3):364-70. PubMed ID: 1346800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases.
    Robak T; Błasińska-Morawiec M; Krykowski E; Hellmann A; Lewandowski K; Dmoszyńska A; Adamczyk-Cioch M; Kazimierczak M; Trepińska E; Dwilewicz-Trojaczek M; Kuratowska Z; Skotnicki AB; Nowak WS; Zdziarska B; Urasiński I
    Eur J Haematol; 1997 Oct; 59(4):216-20. PubMed ID: 9338619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retreatment of chronic lymphocytic leukemia with 2-chlorodeoxyadenosine (CdA) at relapse following CdA-induced remission: no acquired resistance.
    Juliusson G; Liliemark J
    Leuk Lymphoma; 1994 Mar; 13(1-2):75-80. PubMed ID: 8025525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-chloro-2'-deoxyadenosine: clinical applications in hematology.
    Delannoy A
    Blood Rev; 1996 Sep; 10(3):148-66. PubMed ID: 8932828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphoma.
    Tefferi A; Witzig TE; Reid JM; Li CY; Ames MM
    J Clin Oncol; 1994 Mar; 12(3):569-74. PubMed ID: 8120555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
    Zimmer-Molsberger B; Knauf W; Thiel E
    Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and induction of apoptosis in B cell chronic leukemia by diosgenyl 2-amino-2-deoxy-beta-D-glucopyranoside hydrochloride and its derivatives.
    Myszka H; Bednarczyk D; Najder M; Kaca W
    Carbohydr Res; 2003 Jan; 338(2):133-41. PubMed ID: 12526837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
    Santana VM; Mirro J; Harwood FC; Cherrie J; Schell M; Kalwinsky D; Blakley RL
    J Clin Oncol; 1991 Mar; 9(3):416-22. PubMed ID: 1671875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
    Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
    Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The purine analogs--a therapeutic beauty contest.
    Cheson BD
    J Clin Oncol; 1992 May; 10(5):868-71. PubMed ID: 1349035
    [No Abstract]   [Full Text] [Related]  

  • 39. Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.
    Riccioni R; Caracciolo F; Galimberti S; Cecconi N; Petrini M
    Hematol Oncol; 2003 Dec; 21(4):163-8. PubMed ID: 14735554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The purine analogs--a therapeutic beauty contest.
    Cheson BD
    J Clin Oncol; 1992 Mar; 10(3):352-5. PubMed ID: 1346799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.